by Kv4.x-subunits. DPP6 modulates trafficking, kinetics, and pharmacology of Kv4.x-encoded channels. [6] [7] [8] I to underlies the early-repolarization phase of cardiac action potentials (APs) 9 and shows marked transmural variability. 10 Alterations in myocardial I to expression play important roles in cardiac arrhythmias 11 and have been implicated in Brugada syndrome, although precise mechanisms remain controversial. 12 Cardiac Purkinje fibers (PFs) form a specialized conducting system, with unique properties and important roles in cardiac physiology and arrhythmia generation. 13 There are major differences in I to between ventricular muscle (VM) and PFs in many species, including humans. 13, 14 PF I to typically shows slower inactivation and much greater tetraethylammonium (TEA) sensitivity than VM. 13, 14 The molecular mechanisms underlying these differences are unclear. The β-subunit K +channel interacting protein type-2 (KChIP2), which plays a crucial role in VM I to , is weakly expressed in PF. 15 In addition to KChIP2 and DPP6, other potential Kv4.2/4.3-interacting subunits include neuronal calcium sensor-1 (NCS-1) and KCNE1-5, [16] [17] [18] [19] many of which are expressed in the heart. 20 DPP6 is known to confer TEA sensitivity on Kv4.x-subunitbased channels on heterologous expression. 8 We hypothesized that DPP6 may contribute to PF I to and that its overexpression might alter PF I to properties in a way that contributes to IVF occurrence. The present study was designed (1) to assess the expression of various β-subunits in human VM and PF tissue, (2) to evaluate the result of DPP6 overexpression and knockdown by adenoviral gene transfer on VM and PF I to , and (3) to study the properties of I to resulting from heterologous coexpression of different combinations of putative β-subunits relevant to composition in human VM and PF. Our results point to an important contribution of DPP6 to PF I to and implicate enhanced PF I to as a novel candidate mechanism for IVF.
Methods
For further details, see the online Data Supplement.
Clinical Assessment of IVF Patients
Five IVF patients with confirmed 7q36 DPP6-associated haplotype were studied. Baseline clinical data were obtained for all. One patient underwent invasive electrophysiological study and long-term follow-up.
Human Cardiac Tissue Samples
Hearts from 15 nondiseased donors (8 for mRNA and 7 for protein extraction) were stored in cardioplegic solution at 4°C. PF false tendons, left ventricular (LV) epicardium, midmyocardium, and endocardium were dissected and snap-frozen in liquid N 2 .
mRNA Quantification
RNA was extracted with TRIzol, chloroform extraction, and isopropanol precipitation. Genomic DNA was eliminated with DNase I, followed by phenol-chloroform acid. First-strand cDNA was synthesized by reverse transcription with 1 μg RNA, random primers, and moloney murine leukemia virus reverse transcriptase. Real-time polymerase chain reaction was conducted (primers are given in Online Table I ) with SYBR green. 18S rRNA was the internal standard. mRNA was quantified with comparative threshold cycle quantification (ΔΔCt).
Immunoblotting
Membrane protein fractions were run on 10% SDS-PAGE gels and transferred to polyvinylidene fluoride membranes. Blots were probed with primary antibodies against Kv4.3, KChIP2, NCS-1, DPP6, and GAPDH. Results were analyzed with Quantity-One, and data were normalized to GAPDH.
Native-Cell Isolation and Culture
Experiments were performed with canine cardiac tissues, which have relative VM and PF cell (PC) I to properties similar to those of humans. 13, 14 Adult male mongrel dogs (19-30 kg, n=33) were anesthetized with pentobarbital (30 mg/kg IV). After excision of PF false tendons, the anterior LV (or in selected experiments, right ventricular [RV] free wall) was arterially perfused with Tyrode solution containing collagenase (120 U/mL, Worthington, type II). VM cardiomyocytes were isolated as previously described. 21 PCs were obtained by digestion with elastase and collagenase (for details, see Online Methods). Isolated cells were either put in storage solution for study on the same day or placed in cell culture on laminin-coated glass coverslips. In some cases, attached PCs and VMs were subjected to adenovirus infection for 2 to 4 hours and incubated for 48 hours. After culture, PCs and VMs were washed and stored at 4°C for electrophysiological study.
Adenovirus Constructs
A bicistronic construct encoding triple FLAG-tagged DPP6 and green fluorescent protein (GFP) under control of the cytomegalovirus promoter was generated by inserting the cDNA into pShuttle-IRES-hrGFP-1 vector. The adenoviral vector containing DPP6 cDNA is designated Adv-GFP-DPP6, and the control vector containing only GFP is designated Adv-GFP-control.
DPP6 knockdown was obtained with a microRNA-embedded short-hairpin RNA (shRNA-mir 57 ) sequence, targeted to the canine DPP6 mRNA (GeneBank identification, XM_532774). The shRNA-mir sequence was delivered into the cultured cells by a human adenovirus-based vector (Adv-GFP-DPP6-knockdown). A scrambled shRNA-mir carrying adenovirus was used as a negative control (Adv-GFP-Scr). KChIP2 knockdown virus and a scrambled control construct were prepared similarly. Adenovirus vector construction followed previous studies. 22, 23 For details, see online Data Supplement Methods. GFP expression was used to select cells with effective gene transfer.
Chinese Hamster Ovary Cell Culture and Transfection
Chinese hamster ovary (CHO) cells were cultured in F12-medium supplemented with bovine serum and penicillin/streptomycin. 
Immunoprecipitation Studies
Total proteins from CHO cells after 2-day transfections extracted with lysis buffer were fast-frozen and stored at −80°C. Immunoprecipitation was performed with a monoclonal anti-Kv4.3 antibody. Dynabeads M-280/sheep antimouse IgG were washed with PBS and preincubated with 1% BSA for 1 hour at room temperature to minimize nonspecific binding. Anti-Kv4.3 antibodies were incubated overnight at 4°C with 100 μL Dynabeads per sample. The anti-mouse IgG-coated beads were then washed 5 times with PBS and incubated overnight with 100 μg protein extracts from CHO cells, and supernatants were collected. The bead-antibody target protein complexes were washed and subjected to magnetic precipitation/resuspension. Bound Kv4.3 protein complexes were eluted and denatured. Eluted proteins and supernatants were separated on 10% SDS-PAGE gel and transferred to polyvinylidene fluoride membranes. Blots were incubated overnight at 4°C with primary antibodies against Kv4.3, KChIP2, NCS-1, or DPP6. Protein bands were detected by chemiluminescence, and results were analyzed with Quantityone software.
Confocal Microscopy
Two days after transfection, CHO cells were washed with PBS, then fixed with 2% paraformaldehyde, and washed 3 times with PBS. After blocking and permeabilization, cells were incubated overnight at 4°C with primary antibody against Kv4.3 in PBS containing 1% normal donkey serum and 0.05% Triton, followed by 3 washes and incubation with secondary antibody and wheatgerm agglutinin. Confocal microscopy was performed with a Zeiss LSM-710 system. Images were deconvolved using measured point-spread functions. Kv4.3 fluorescence densities were determined as the sum of the pixels within each region normalized to region area. Measurements were repeated in 5 Z stacks for each cell.
Electrophysiology
Whole-cell patch-clamp technique was applied for I to recording at 36±0.5°C (native cells) or 22±0.5°C (CHO cells). I to was always defined as the difference between peak and end-pulse current. Cell capacitances were not significantly different among groups (Online Table II ). Recording solutions were as previously described [14] [15] [16] (see online Data Supplement).
Data Analysis
Clampfit 9.0 (Axon) and GraphPad Prism 5.0 were used for basic data analysis. Real-time polymerase chain reaction results were analyzed with MXPro software. Statistical comparisons were performed with paired or unpaired Student t tests for 2-group-only analysis and by ANOVA followed by Bonferroni-corrected t tests for multiple-group comparisons. A 2-tailed value of P<0.05 indicated statistical significance; group data are mean±SEM.
PF AP Model
A previously described model of the electrophysiology of the PF cell was used, 24 modified to reproduce behavior of canine cell recordings at physiological temperature. Current density was set to reproduce a peak current of 10 pA/pF at 30 mV. 25
Results

IVF Patients
Baseline ECGs were normal in DPP6 risk-haplotype carriers (Online Table III ). Ventricular arrhythmia manifested as short coupled ventricular extrasystoles (VESs) that sometimes initiated rapid polymorphic ventricular tachyarrhythmias (Online Figure I ). VESs consistently displayed left bundle-branch block morphology and superior/leftward ECG axis, suggesting a lower RV origin. The short VES coupling intervals despite normal QTc, along with the relatively narrow QRS complexes, suggest an origin in the conduction system, as observed by Haïssaguerre et al 26 in 25% of their IVF patients. In 1 patient undergoing ablation for repeated arrhythmia storm after implantation of a cardioverter-defibrillator ( Figure 1 ), RV pace mapping produced a morphology similar to that of VESs ( Figure 1A and 1B). Radiofrequency ablation was applied at a site with early diastolic PF potentials ( Figure 1C ) in the anterior lower RV ( Figure 1D ). During the 43-month follow-up, neither ventricular fibrillation nor typical-morphology VESs occurred. Figure II) . Overall current densities are of the same order for PCs and VMs ( Figure 2C and 2D). Both PF I to and VM I to show biexponential inactivation ( Figure 2E) ; however, the slow-phase inactivation time constants were slower for PF ( Figure 2F and 2G). For example, the time constants at 30 mV averaged 8.3±1.0 milliseconds (fast phase) for PF versus 4.6±0.4 milliseconds for VM (P=0.005), and the slow-phase time constants averaged 66.5±15.4 milliseconds for PF versus 13.5±2.0 milliseconds for VM (P=0.044). The relative proportion of inactivation attributable to fast-phase inactivation was smaller in PF (57±6%) compared with VM (72±2%; P<0.05). Figure 3 shows inactivation voltage dependence and recovery kinetics for PCs versus VM. Inactivation voltage dependence ( Figure 3A and 3B) tended to be less negative in PCs: 50% inactivation voltages were −28.5±0.6 mV (PF) versus −34.0±2.8 mV (VM; P=0.184). Fast-phase recovery time constants were similar: 30±5 milliseconds for PF versus 21±4 milliseconds for VM (P=NS), but slow-phase recovery time constants were much slower for PF (691±139 milliseconds) compared with VM (166±48 milliseconds; P=0.04). The slow phase also comprised a larger portion of total inactivation in PF, 61±6%, compared with VM (39±7%; P=0.04). I to properties were stable over 2 days in culture (Figures 2 and 3) .
Differences Between PC and VM I to
A signature property of PC I to is TEA sensitivity. 13, 14 PC and VM responses to TEA (10 mmol/L) are illustrated in Figure  4A and 4B. TEA 10 mmol/L reduced PC I to by ≈50% at 50 mV ( Figure 4C ). The dose-response relation for TEA inhibition of fresh PC I to (Online Figure IIIA) showed a 50% inhibitory concentration (IC 50 ) of 2.0±1.6 mmol/L. Neither inactivation time constants (Online Figure IIIB) nor the percentage of fastversus slow-phase inactivation was changed by 100 mmol/L TEA. Recovery was accelerated by 10 mmol/L TEA (Online Figure IIIC ) because of a decrease in the slow-phase proportion from 77±4% to 41±3% (P<0.01) without any change in the time constants per se. In contrast, VM I to was unaffected by 10 mmol/L TEA ( Figure 4D ) and nonsignificantly decreased with 100 mmol/L TEA (Online Figure IIID) . The relative responses of PCs versus VMs were unchanged after a 2-day culture ( Figure 4E and 4F).
All VM studies described above were performed in LV cells. We also compared PC I to properties with those of RV cardiomyocytes. RV I to was insensitive to 10 mmol/L TEA (Online Figure IVA) , quite different from PCs (Online Figure   IVB ). Similar to LV VM, RV I to inactived faster than PC (Online Figure VA and VB). The voltage dependence of I to inactivation was less negative for PC I to compared with RV (Online Figure VC) . Recovery kinetics were also faster in RV cardiomyocytes compared with PCs (Online Figure VD) . Overall, differences between PCs and RV cardiomyocytes paralleled those for LV cardiomyocytes.
Effects of DPP6 Expression Changes on PC and VM I to
To assess the effect of DPP6 overexpression, as occurs in 7q36-IVF, on PC and VM I to , we used adenovirus-based DPP6 gene transfer ( Figure 5A and 5B). DPP6 overexpression significantly increased both I to density (by ≈52%; Figure  5C ) and TEA sensitivity ( Figure 5D ) in PCs but did not alter current density ( Figure 5E ) or TEA sensitivity ( Figure 5F ) in VMs. DPP6 overexpression did not alter I to inactivation kinetics or voltage dependence (Online Figure VI) . The time course of recovery from inactivation was similarly unaffected by DPP6 overexpression (Online Figure VII) . Effective overexpression was confirmed at the mRNA level (Online Figure VIIIA) . To further assess the potential role of DPP6 in PC and VM I to , we studied the effects of DPP6 knockdown on native I to . Effective DPP6 knockdown was confirmed by measuring DPP6 mRNA (Online Figure VIIIB) . Examples of I to in PCs and VMs infected with the scrambled control and DPP6knockdown virus are shown in Figure 6A and 6B. DPP6 knockdown significantly decreased PC I to density ( Figure 6C ) and TEA sensitivity ( Figure 6D ) but did not affect VM I to ( Figure  6E and 6F). Inactivation kinetics and voltage dependence, recovery kinetics, and relative amplitudes were not affected by DPP6 knockdown for both PC and VM I to (Online Figure IX) .
Purkinje Fiber Versus Myocardial Expression of I to -Related Subunits
The studies shown in Figures 5 and 6 support the contention that DPP6 is an important contributor to PC (but not VM) I to . To evaluate potential underlying mechanisms, we first assessed the differential expression of potential I to subunits in PFs and VMs. Normal human hearts presented marked DPP6 mRNA expression gradients between PF and LV ( Figure 7A ). DPP6 mRNA expression was 29±10-, 23±7-, and 15±5-fold higher in PF compared wtih LV epicardium, midmyocardium, and endocardium, respectively ( Figure 7A , inset). Kv4.3, Kv3.4, and Kv1.4 were similarly expressed in PF and LV, with Kv4.3 expression being by far the strongest. KChIP2b expression in LV epicardium was ≈5-fold greater than in PF, whereas NCS-1 was more strongly expressed (≈4-fold) in PF. KCNE1, KCNE2, and KCNE3 mRNA levels were not differential. We also measured the expression of Kv4.3, KChIP2, NCS-1, and DPP6 proteins in PF and VM membrane preparations from normal human hearts ( Figure 7B and 7D) and from canine hearts ( Figure 7C and 7E). The protein expression differences for Kv4.3, KChIP2, NCS-1, and DPP6 in PF and VM qualitatively paralleled relative transcript expression ( Figure 7A ), with KChIP2 more strongly expressed in VM and NCS-1 and DPP6 more strongly expressed in PF. Kv4.3 protein levels were not significantly different between PF and VM. Membrane extracts from CHO cells overexpressing the various subunits studied were probed with the antibodies used, showing good selectivity (Online Figure X) . 
Effects of β-Subunit Background on Heterologously Expressed Kv4.3
To relate the different properties of VM compared with PF I to to the various subunits they express, we studied the effects of DPP6 on Kv4.3+KChIP2 (mimicking VM I to subunit makeup) or Kv4.3+NCS-1 (mimicking PC I to subunit makeup) in CHO cells. Figure 8A Figure 8G . KChIP2 enhanced I to current density ( Figure 8B versus 8A) , but the addition of DPP6 produced no further change ( Figure 8C and 8G). NCS-1 cotransfection with Kv4.3 increased I to slightly compared with Kv4.3 alone ( Figure 8D) , and the addition of DPP6 substantially enhanced I to ( Figure 8E ). DPP6 alone enhanced I to to about the same extent as DPP6 in the presence of NCS-1 ( Figure 8F and 8G). Changes in mean inactivation time constants are shown in Figure 8H , with illustrative fits in Figure 8I . Although the expression data do indicate stronger DPP6 expression in PF compared with VM, the protein data indicate relatively small quantitative rather than the qualitative differences seen with mRNA. We therefore considered the possibility that the prominent role of DPP6 in PF might be the result of interference with DPP6-Kv4.3 interaction by KChIP2, the predominant I to β-subunit in VM that is weakly expressed in PCs, based on the lack of change in current density when DPP6 is added to Kv4.3+KChIP2 ( Figure 8G ) and the inability of DPP6 to induce TEA sensitivity when cotransfected with Kv4.3+KChIP2 (Online Figure XIIC) . To study the physical interaction of various combinations of β-subunits with Kv4.3, we immunoprecipitated proteins from CHO cells expressing Kv4.3, Kv4.3+KChIP2, Kv4.3+KChIP2+DPP6, Kv4.3+DPP6, Kv4.3+NCS-1, or Kv4.3+NCS-1+DPP6 with a monoclonal anti-Kv4.3 antibody (Online Figure XIIIA) Figure XIIIB) .
Potential Basis for Kv4.3 Current Enhancement by KChIP2 and DPP6
Either KChIP2 or DPP6 substantially enhances K4.3 current.
To gain insights into possible mechanisms, we assessed CHO Figure XIV) and in crude membrane preparations with Western blot (Online Figure XV) . Both approaches suggest that KChIP2 or DPP6 increases Kv4.3 membrane expression. Figure XVIB) . KChIP2 knockdown did not significantly affect I to density (Online Figure XVIC) .
Effects of KChIP2 Knockdown on VM I to
Effects of Increased I to on PC APs in a Mathematical Model
Our studies of the properties of PFs versus VM, of the effect of DPP6 overexpression and knockdown on native PCs and VMs, of putative I to subunit composition, and of the results of cotransfection of Kv4.3 with different subunit combinations in CHO cells all point to an important role of DPP6 in PF I to composition and suggest that increased DPP6 expression enhances PF I to . We then sought to understand the potential functional consequences of DPP6 overexpression. We were unable to record physiological APs from cultured PCs. We therefore turned to a previously described computational model of the PC AP. 24 Online Figure XVIIA 
Discussion
The recent discovery of a founder risk haplotype on chromosome 7q36, which includes the proximal and upstream regions of the DPP6 gene, in Dutch familial IVF subjects brought the potential for new insights into our understanding of the mechanisms underlying IVF. 4 In risk-haplotype carriers, IVF is highly linked to cardiac overexpression of the DPP6 gene, 4 pointing to increased DPP6 expression as a potential molecular basis. However, the link between DPP6 upregulation and arrhythmogenesis has been unclear. In the present study, we examined clinical data from 5 DPP6 riskhaplotype carriers who had suffered IVF and found that DPP6-related IVF arrhythmias likely originated from the PF system. In nondiseased human hearts, we observed that DPP6 is more richly expressed in PFs compared with its expression in VMs. Besides DPP6, we found PF-VM differences in the expression of KChIP2 and NCS-1, with KChIP2 being more abundant in VMs and sparse in PFs, whereas NCS-1 is more strongly expressed in PFs than VMs. The biophysical and pharmacological properties of PF I to are known to differ from those of VM I to , 13, 14 but the underlying molecular mechanism has been unknown. In addition, the basis for substantial PF I to density has been mysterious, in light of weak PF expression of KChIP2, 15 known to be essential for VM I to expression. 27 The data presented here suggest that DPP6 performs a function in PFs comparable to that of KChIP2 in VMs, permitting normal current expression of I to . In addition, NCS-1 and DPP6 recapitulated the specific functional PF I to phenotype when coexpressed with the α-subunit Kv4.3, and DPP6 knockdown suppressed native PC I to . Overexpression of DPP6 to mimic the particular cardiac gene expression phenotype observed in IVF patients enhances PF (but not VM) I to ; in vivo, this would translate into accelerated PF repolarization, which might cause a form of PF early-repolarization syndrome.
Possible Role in Arrhythmogenesis
Cardiac PFs participate in the initiation and maintenance of ventricular arrhythmias in the presence of pathology like congestive heart failure or myocardial infarction or in inheritable arrhythmic syndromes like the long-QT syndrome. [28] [29] [30] [31] They have also been implicated in catecholaminergic polymorphic ventricular tachycardia. 32 PFs are particularly susceptible to early afterdepolarizations or delayed afterdepolarizations. 33, 34 Ion channel remodeling in PFs contributes to arrhythmogenic electrophysiological abnormalities in diseased hearts. 14, 24, [35] [36] [37] Our discovery that upregulation of DPP6 expression specifically enhances I to in cardiac PF but not VM is the first mechanistic clue to the pathogenesis of DPP6-related IVF. The absence of alterations in ventricular I to with DPP6 overexpression potentially explains the normal ECG in risk-haplotype carriers because the Purkinje system is a small fraction of the myocardial mass. Imbalances between I to and inward currents have been suggested to underlie the development of ventricular arrhythmias. KCND3 (encoding Kv4.3) or KCNE3 gain-of-function mutations seen in Brugada syndrome patients enhance ventricular I to and are presumed to cause steep transmural repolarization gradients that induce spontaneous generation of ectopic beats. 38, 39 In the risk haplotype for IVF, increased Purkinje I to expression with DPP6 enhancement might similarly deepen phase 1 and appreciably accelerate repolarization (Online Figure XVII) . Accelerated PF repolarization could cause strong local repolarization gradients with adjacent ventricular muscle (unaffected by DPP6 overexpression), thereby generating local ectopic activity that produces early coupled VESs without other evidence of electrocardiographic early-repolarization syndromes. This interesting possibility remains to be tested directly.
I to Subunit Composition and Properties
The TEA sensitivity of PF I to was a classic observation that contributed to the recognition that I to is carried predominantly by K + . 40 In contrast, VM I to is TEA insensitive. 13, 14 Similarly, I to recovery is markedly slower in PFs compared with VM, 13, 14 contributing to well-established differences in AP rate responsiveness. 41 Nevertheless, the molecular basis for Purkinje I to has not been established despite studies of PF I torelated subunit composition. 15, 20, 42, 43 In addition to permitting normal I to densities in the virtual absence of KChIP2, the subunit profiles we noted here may account for the unique TEA sensitivity and kinetic properties of PF I to : DPP6 bequeathing TEA sensitivity and NCS-1 slow recovery. In previous studies, we found higher levels of Kv3.4 in PFs than in VM (findings we could not confirm here), identifying Kv3.4 as a potential contributor to Purkinje I to . 15 However, the TEA sensitivity of Kv3 channels is an order of magnitude greater than that of Purkinje I to , and high concentrations of blood-depressing substance, a potent and specific Kv3.4 channel blocker, fail to inhibit Purkinje I to . 13 The results here present for the first time a plausible basis for the previously enigmatic molecular composition of Purkinje I to .
KChIP2 and NCS-1 are members of the recoverin/NCS subfamily of calcium-binding proteins. 44, 45 Both proteins can interact with Kv4 channels and are recognized as regulatory subunits for Kv4 subunit channels in neuron and myocardium. 5, 10, 16, 17, 44, 45 The specific role of NCS-1 in the heart has not been determined. Nakamura et al 16 initially suggested that NCS-1 regulates K4 currents. Guo et al 17 showed that NCS-1 is expressed in mammalian myocardium, slows Kv4 current inactivation, and enhances current density. In mouse, NCS-1 is developmentally regulated and more abundant in immature hearts. 45 Relatively little is known about the regional distribution of NCS-1 expression. Greener et al 42 found greater frequenin (NCS-1) mRNA levels in the bundle of His (composed of PCs) than in VM. Extremely low-level KChIP2 expression in PFs is a consistent finding. 15, 20, 42, 43, 46 Our finding of greater PF DPP6 abundance compared with VM is consistent with other recent observations. 42, 43 The interaction of DPP6 with Kv4.x subunits is also known to facilitate subunit trafficking and to alter current kinetics. 5, 6, 8, 47 The effect of DPP6 on Kv4 subunit channel TEA sensitivity is related to modified TEA binding to the external side of the pore. 8, 48 Our coexpression studies suggest that both NCS-1 and DPP6 contribute to the properties of PF I to , with DPP6 required to enhance Kv4.3 current density and TEA sensitivity and NCS-1 necessary for the typical kinetic properties (slower inactivation and recovery). These observations provide new insights into the functional importance of differential PF-VM I to subunit expression profiles.
Potential Limitations
In this study, we developed a novel in vitro system of cultured PCs and applied it to study the consequences of DPP6 overexpression, as seen in IVF, for PF I to . We were unable to record physiologically relevant APs from cultured PCs, which prevented us from directly assessing the impact of DPP6 overexpression on PC APs. Instead, we used a mathematical PC-AP model to analyze the effect of PF I to gain of function. Further work is needed to explore the electrophysiological phenotype associated with DPP6 overexpression. Because of the brief murine AP, studies in transgenic models more closely related to humans such as the rabbit 49 may be needed. Interspecies differences in I to also exist between the human and canine heart 50 and need to be considered in the assessment of the application of our findings. May 10, 2013
We compared I to kinetics in native PCs and VMs with identical 100-millisecond depolarizing pulse protocols (Figure 3 ). Although these studies allowed us to demonstrate slower I to inactivation in PCs compared with VM, because of the slow nature of PC I to recovery, the slow-phase time constants could not be accurately quantified with such short pulses. We subsequently used a 1-second depolarizing pulse protocol and obtained results suggesting that the slow-phase time constant is at least on the order of 400 milliseconds (Online Figure XVIII) .
Our DPP6 overexpression and knockdown data indicate that DPP6 plays a significant role in PF but not in VM I to , but our studies do not establish a clear molecular basis for this highly PF-selective contribution. DPP6 and NCS-1 are more strongly expressed in human PF than VM at both the protein and mRNA levels ( Figure 2) ; however, the PF-VM discrepancy is much greater in mRNA than protein expression. The mRNA data are more strictly quantitative than the protein data but are further removed from the functional molecule. The protein data are based on membrane preparations that include a variety of cell membranes and not solely the sarcolemma; in addition, the protein data do not reflect compartmentalization in potentially critical macromolecular complexes. Western blot analyses are limited by imperfect specificity and the detection of multiple molecular weight bands, particularly for polyclonal antibodies. KChIP2 seems to prevent Kv4.3 interaction with DPP6, as reflected by the lack of Kv4.3 current increase with DPP6 in the presence of KChIP2 compared with KChIP2-Kv4.3 alone ( Figure 8G ), the inability of DPP6 to confer TEA sensitivity in the presence of KChIP2 (Online Figure XIIC) , and the reduction in DPP6 physical interaction with Kv4.3 in the presence of KChIP2 (Online Figure  XIII) . Thus, the low-level expression of KChIP2 in PF may contribute at least as much to the manifest role of DPP6 as the PF-VM differences in DPP6 expression per se. In contrast, coexpression with NCS-1 does not interfere with any DPP6 effects and is required to reproduce slow PC recovery kinetics. It must be noted that although our study clarifies the basis of unusual PF I to properties by suggesting that the characteristic slowly recovering and TEA-sensitive components are likely caused by the involvement of NCS-1 and DPP6, by indicating that PF I to current amplitude is maintained by DPP6 in the relative absence of KChIP2, and by pointing to PF early repolarization as a mediator of arrhythmogenic consequences of DPP6-overexpressing arrhythmia syndromes, many questions about the molecular composition of PF I to remain unanswered and need to be addressed in future work. It is likely that PF I to consists of >1 channel type because TEA blocked a maximum of ≈75% of the current and selectively suppressed the slowly recovering kinetic component.
Studies in native cells are essential to assess the composition of native channels but are limited by the variability introduced by varying cell quality and ionic current densities. For this reason, we were as careful as possible to study all groups and interventions within each series of experiments in contemporaneous experiments and whenever possible within each set of cells. We studied native-cell properties at a physiological temperature (36°C) to work under as physiological conditions as possible. However, currents in heterologously expressing cells were too large at 36°C to be effectively voltage clamped. Therefore, heterologous cell work was done at room temperature, greatly slowing current kinetics. Comparisons with native-cell data are therefore based on qualitative findings rather than quantitative comparisons between corresponding kinetic components.
Translational Relevance
Our study is the first to address the pathophysiological mechanism of DPP6-related IVF. Familial IVF linked to the chromosome-7 locus including DPP6 presents as a malignant inheritable arrhythmia syndrome. 4, 51 The genetic findings enable risk stratification, 4, 51 and elucidation of the underlying electrophysiological mechanism is important to develop improved treatment. For example, our results provide a potential rationale for the efficacy of quinidine, an I to blocker, in IVF patients, as reported previously. 52 The concepts we elucidated may also aid in understanding potential mechanisms of IVF and in facilitating exploration of mechanisms associated with other novel genes 53 and sudden arrhythmic death paradigms.
